PepGen Inc.
Status: Publicly traded
Direct answer
PepGen Inc. is publicly traded on NASDAQ under the ticker PEPG.
PepGen Inc. is a clinical-stage biopharmaceutical company specializing in the development of oligonucleotide therapeutics designed to treat severe neuromuscular and neurological disorders. Its most advanced candidate, PGN-EDO51 – an EDO peptide – is currently undergoing Phase 1 clinical trials for individuals suffering from Duchenne muscular dystrophy (DMD). The company's pipeline also includes PGN-EDODM1, an EDO...
Can you invest in PepGen Inc.?
Yes. PepGen Inc. is publicly traded on NASDAQ under the ticker PEPG.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Detailed equity research is provided by MarketSnap.